Bacil Pharma fundamental analysis

BACPHAR

44.7

0.45 (1.02%)
Last updated on 19 Jan, 2026 | 15:28 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Bacil Pharma Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

70.09

Sector P/B

1

Sec. Div. Yield

0.57

Bacil Pharma Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 70.09. Its P/B Ratio stands at 0, while the sector’s is 1. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.

Bacil Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Bacil Pharma reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.